[Implementation of the reverse screening syphilis algorithm in a clinical laboratory].

Syphilis diagnosis relies on serological testing, with two main diagnostic algorithms in use. The traditional algorithm begins with a non-treponemal test followed by a treponemal test. The reverse algorithm reverses this sequence. Prior research has shown that non-treponemal tests like VDRL can miss early infections. This gap motivated a study to compare the reverse algorithm’s performance in a clinical setting. Treponemal tests are known for high specificity but may lack sensitivity in early stages. No prior work had resolved how automation and traceability affect diagnostic outcomes. The need for accurate early detection remains unmet. This study aimed to address these uncertainties in a real-world clinical context.

The study aimed to evaluate the reverse screening algorithm for syphilis in a clinical laboratory setting. It focused on comparing the diagnostic performance of the reverse algorithm against the traditional approach. The researchers proposed to assess sensitivity in detecting primary infections. They also aimed to evaluate automation benefits and traceability features. The motivation stemmed from the limitations of non-treponemal tests in early stages. The goal was to determine if the reverse algorithm could reduce false positives. The study sought to provide evidence for algorithm adoption in clinical labs. It aimed to inform best practices for syphilis diagnosis.

The observational cross-sectional study analyzed 246 reactive sera from 14,700 syphilis serology requests. The ARCHITECT Syphilis TP chemiluminescent assay was used as the initial test. Reactive samples were followed by VDRL and FTA-Abs testing. A total of 129 sera remained reactive after VDRL testing. Of these, 97 were reactive and 20 non-reactive in FTA-Abs, suggesting false positives. Two primary infection cases were identified that VDRL missed. One pregnant patient had a high S/CO ratio and VDRL:1 dilution. The study compared test outcomes and automation features of the reverse algorithm.

The reverse algorithm detected two primary infections missed by VDRL. One pregnant patient had a high S/CO ratio and a positive VDRL result. Among 246 reactive sera, 129 remained reactive after VDRL testing. Of these, 97 were reactive and 20 non-reactive in FTA-Abs, indicating false positives. The false positive rate was 0.13% overall. The reverse algorithm showed greater sensitivity in early-stage detection. Automation and traceability improved diagnostic reliability. The study found conclusive results with objective interpretation.

The reverse algorithm demonstrated advantages in detecting primary syphilis cases. It showed higher sensitivity compared to traditional methods. Automation and traceability features improved diagnostic consistency. The study found fewer false positives with the reverse algorithm. The authors proposed that the reverse algorithm could enhance diagnostic accuracy. It provided objective results and complete traceability. The study supports the use of reverse algorithms in clinical labs. The findings suggest benefits in early-stage detection and automation.